{"transactions":[{"id":830478,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T20:30:11.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":40278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":40278,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":40278},"source":{"system":"sec-edgar","filing":"0001963664-26-000003","document":"form4-03232026_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000003/form4-03232026_040307.xml","form_type":"4"}},{"id":830477,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T20:30:11.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":32526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer.  The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":139917,"source":{"system":"sec-edgar","filing":"0001963664-26-000003","document":"form4-03232026_040307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000003/form4-03232026_040307.xml","form_type":"4"}},{"id":857650,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T23:20:13.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11313,"price":20.99,"value":237459.87,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":107391,"source":{"system":"sec-edgar","filing":"0001963664-26-000002","document":"form4-03052026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000002/form4-03052026_060310.xml","form_type":"4"}},{"id":1059803,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-08-20T21:00:16.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4470,"price":6.8366,"value":30559.602,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":118704,"source":{"system":"sec-edgar","filing":"0001415889-25-022472","document":"form4-08202025_050803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925022472/form4-08202025_050803.xml","form_type":"4"}},{"id":1091688,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:11.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":24459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 15, 2024, the reporting person was granted performance-vesting restricted share units (\"PSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria.  Certain of the performance criteria was determined to have been met effective July 1, 2025.  The shares subject to the PSUs vest as follows:  50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date."}],"balance_after":123174,"source":{"system":"sec-edgar","filing":"0001415889-25-019353","document":"form4-07032025_050708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019353/form4-07032025_050708.xml","form_type":"4"}},{"id":1091687,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:11.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1824,"price":7.9166,"value":14439.8784,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":98715,"source":{"system":"sec-edgar","filing":"0001415889-25-019353","document":"form4-07032025_050708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019353/form4-07032025_050708.xml","form_type":"4"}},{"id":1198135,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-19T00:45:12.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":155040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2026,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":155040,"derivative":{"exercise_price":7.02,"expiration_date":"2035-03-15","underlying":"Ordinary Shares","underlying_shares":155040},"source":{"system":"sec-edgar","filing":"0001415889-25-008553","document":"form4-03182025_080308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925008553/form4-03182025_080308.xml","form_type":"4"}},{"id":1198134,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-03-19T00:45:12.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":63810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer.  The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates."}],"balance_after":100539,"source":{"system":"sec-edgar","filing":"0001415889-25-008553","document":"form4-03182025_080308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925008553/form4-03182025_080308.xml","form_type":"4"}},{"id":1565613,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-20T23:39:52.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":91494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares (\"ADSs\"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest March 1, 2025,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":91494,"derivative":{"exercise_price":11.75,"expiration_date":"2034-03-14","underlying":"Ordinary Shares","underlying_shares":91494},"source":{"system":"sec-edgar","filing":"0001415889-24-008782","document":"form4a-03202024_110344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588924008782/form4a-03202024_110344.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1566907,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-19T20:48:59.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":91494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest March 1, 2025,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":91494,"derivative":{"exercise_price":35.25,"expiration_date":"2034-03-14","underlying":"Ordinary Shares","underlying_shares":91494},"source":{"system":"sec-edgar","filing":"0001415889-24-008569","document":"form4-03192024_080346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588924008569/form4-03192024_080346.xml","form_type":"4"}},{"id":1566906,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-19T20:48:59.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":36729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer.  The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates."}],"balance_after":36729,"source":{"system":"sec-edgar","filing":"0001415889-24-008569","document":"form4-03192024_080346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588924008569/form4-03192024_080346.xml","form_type":"4"}}]}